Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature.
Hefer
David
D
Department of Internal Medicine, St. Luke's/Roosevelt Hospital Center, 1000 Tenth Avenue, New York, NY 10019, USA. hefer.david@earthlink.net
Jaloudi
Mohammed
M
D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D013923:Thromboembolism / Q000097:blood / Q000209:etiology*
D016756:Immunoglobulins, Intravenous